10.1371/journal.pone.0048993.g003 Yann Neuzillet Yann Neuzillet Xavier Paoletti Xavier Paoletti Slah Ouerhani Slah Ouerhani Pierre Mongiat-Artus Pierre Mongiat-Artus Hany Soliman Hany Soliman Hugues de The Hugues de The Mathilde Sibony Mathilde Sibony Yves Denoux Yves Denoux Vincent Molinie Vincent Molinie Aurélie Herault Aurélie Herault May-Linda Lepage May-Linda Lepage Pascale Maille Pascale Maille Audrey Renou Audrey Renou Dimitri Vordos Dimitri Vordos Claude-Clément Abbou Claude-Clément Abbou Ashraf Bakkar Ashraf Bakkar Bernard Asselain Bernard Asselain Nadia Kourda Nadia Kourda Amel El Gaaied Amel El Gaaied Karen Leroy Karen Leroy Agnès Laplanche Agnès Laplanche Simone Benhamou Simone Benhamou Thierry Lebret Thierry Lebret Yves Allory Yves Allory François Radvanyi François Radvanyi Combined <i>FGFR3</i> and <i>TP53</i> mutation frequencies according to the stage/grade group. Public Library of Science 2012 mutation frequencies 2012-12-13 01:42:56 Figure https://plos.figshare.com/articles/figure/_Combined_FGFR3_and_TP53_mutation_frequencies_according_to_the_stage_grade_group_/196176 <p>Proportion of tumours with both <i>FGFR3</i> and <i>TP53</i> mutations (orange), with <i>FGFR3</i> mutations and wild-type <i>TP53 wild-type</i> (grey), with wild-type <i>FGFR3</i> and mutated <i>TP53</i> (purple), or with wild-type <i>FGFR3</i> and wild-type <i>TP53</i> (blue), as a function of stage/grade. The number of cases in each subgroup is indicated in the corresponding rectangle.</p>